GSK IMMUNISATION GRANTS
In 2018, the GSK Immunisation Grants will again be managed by the Public Health Association of Australia (PHAA) as part of the 16th National Immunisation Conference to be held in Adelaide from the 5th -7th June 2018.
Four grants of $20,000 each, will be awarded to support innovation programs of activity that clearly aim to meet one or more of the following criteria in either childhood, adolescent and/or adult vaccines:
Improve access, coverage and/or timely delivery as per the Australian National Immunisation Program schedule;
Improve access, coverage and/or timely delivery for hard-to-reach populations (including geographically distant populations, new Australian immigrants, refugees, asylum seekers);
Utilise digital technology and/or social media to improve the Quality Use of Vaccines through innovation;
Improve access, coverage and/or timely delivery for indigenous populations;
Improve access, coverage and/or timely delivery for international travellers.
Objectives of the grants are to improve the update, compliance, timeliness and/or awareness of immunisation in Australia.The projects submitted for entry should be innovative, and adaptable by other immunisation groups.
To download a copy of the GSK Immunisation Grants flyer please click here.
Call for abstracts open - Monday 15 January 2018
Call for abstracts close - Friday 23 February 2018, 5pm AEDT
Notification of abstract submissions - Thursday 15 March 2018
Finalist Applications open - Thursday 15 March 2018
Finalist applications closed - Wednesday 4 April 2018, 5pm AEST
Announcement of 2018 GSK Immunisation Grants - Wednesday 6 June 2018
GRANT APPLICATION PROCESS - NOW CLOSED
Phase 1 – Call for Abstracts
A Call for abstracts will take place for phase 1 of the Grants application process. Each response should be no longer than 300 to 500 words responding to one or more of the criteria. Once the call for abstracts closes, submissions will be reviewed and finalists notified. Finalised will then be asked to submit an application for the Grant in phase 2.
Abstract should be submitted using the Call for Abstracts Submission Form.
Call for abstracts closed 5pm AEDT, Friday 23 February 2018
To download a copy of the Call for Abstracts flyer please click here.
Phase 2 – Finalists Applications
Once finalists have been notified of their successful call for abstracts submission, they will be requested to submit the grant application.
The application must include a response to one or more of the criteria, as identified in the call for abstracts submission. Each response should be no more than 2000 words.
The application to be accompanied by at least one testimonial from a stakeholder, including examples of activities which have inspired the Application.
Applications will be submitted using the appropriate Application Form and be sent through with supporting documentation attached.
Grant winners will be notified at the 16th National Immunisation Conference Dinner on Wednesday 6 June 2018.
The following benefits will be offered to Recipients of the 2018 GSK Immunisation Grants:
An award trophy, which is theirs to keep;
An award certificate; and
A financial grant of $20,000 to be used towards achieving innovation and best practice in childhood and adult immunisation.
Finalists should use their best endeavours to attend or be represented at the Award Ceremony at the 16th National Immunisation Conference.
Finalists will be invited to attend the Dinner with up to 2 tickets per finalist application provided complementary.
The awards will be presented during the 16th National Immunisation Conference. The presentations will be made by the PHAA CEO and the sponsor of that award.
Winners will receive a $20,000 grant prize. The grant prize will be divided up into two allotted amounts for project reporting purposes of the grant awards.
Stage 1 - $15,000 of the grant funding will be awarded following the announcement of the winners via direct deposit within three (3) business days following the announcement to the nominated organisation/representative of the grant project identified on the finalist application form.
Stage 2 - A following $5,000 will be provided once the final grant project report is submitted no later than 5pm AEST on Tuesday 30 April 2019. If the project report is not received by 5pm AEST on Tuesday 30 April 2019, the remaining $5,000 may be forfeited.
Winners of the GSK Immunisation Grants will be required to submit a 1 year project report. A project report template will be provided and needs to be submitted no later than 5pm AEST on Tuesday 30 April 2019. On completion of the 1 year project report, the remaining $5,000 of grant funding will be provided.
TERMS AND CONDITIONS
To view the 2018 GSK Immunisation Grants terms and conditions please click on the button below.
2016 GSK Immunisation Grant winners